|
Clinico-pathological parameters of early- and late-onset BC |
||||||
| Group A |
Group B |
|||||
|
|
|
|||||
| Clinical features |
Case |
Mean age (years) |
Age range (years) |
Case |
Mean age (years) |
Age range (years) |
|
|
||||||
| Histological Type |
||||||
| Ductal |
45 |
34 |
25–40 |
59 |
53 |
41–77 |
| Lobular |
2 |
28 |
20–35 |
0 |
_ |
_ |
| Clinical Stage |
||||||
| TNM Stage I |
1 |
40 |
40 |
2 |
48 |
45–50 |
| TNM Stage II |
7 |
33 |
23–40 |
21 |
51 |
42–61 |
| TNM Stage III |
36 |
35 |
20–40 |
33 |
53 |
41–77 |
| TNM Stage IV |
3 |
37 |
36–38 |
3 |
57 |
48–72 |
| Tumor Differentiation |
||||||
| Grade 1 |
4 |
32 |
20–40 |
8 |
52 |
43–61 |
| Grade 2 |
32 |
33 |
18–40 |
39 |
47 |
41–42 |
| Grade 3 |
11 |
38 |
33–40 |
12 |
56 |
42–77 |
| Lymph Node |
||||||
| Positive |
33 |
35 |
26–40 |
48 |
52 |
42–77 |
| Negative |
14 |
31 |
18–40 |
11 |
51 |
41–65 |
Sinha et al. Molecular Cancer 2008 7:84 doi:10.1186/1476-4598-7-84 |
||||||